GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (LTS:0OIR) » Definitions » Accounts Payable

Alk-Abello AS (LTS:0OIR) Accounts Payable : kr189 Mil (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alk-Abello AS Accounts Payable?

Alk-Abello AS's Accounts Payable for the quarter that ended in Jun. 2024 was kr189 Mil.

Alk-Abello AS's quarterly Accounts Payable increased from Dec. 2023 (kr128 Mil) to Mar. 2024 (kr134 Mil) and increased from Mar. 2024 (kr134 Mil) to Jun. 2024 (kr189 Mil).

Alk-Abello AS's annual Accounts Payable increased from Dec. 2021 (kr115 Mil) to Dec. 2022 (kr131 Mil) but then declined from Dec. 2022 (kr131 Mil) to Dec. 2023 (kr128 Mil).

Alk-Abello AS Accounts Payable Historical Data

The historical data trend for Alk-Abello AS's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Accounts Payable Chart

Alk-Abello AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.00 74.00 115.00 131.00 128.00

Alk-Abello AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 127.00 116.00 128.00 134.00 189.00

Alk-Abello AS Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Alk-Abello AS Accounts Payable Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Alk-Abello AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (LTS:0OIR) » Definitions » Accounts Payable
Comparable Companies
OCSE:ZEAL OCSE:BAVA OCSE:GUBRA OCSE:PEG OCSE:GMAB OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
AKBLF:USA ALK B:Denmark 4AJ0:Germany
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Website
https://www.alk.net
Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello AS Headlines

No Headlines